... of and risk for venous thromboembolism events in patients with RA enrolled in the upadacitinib phase 3 clinical trial program. Industry-Supported Post Meeting Symposia: SPARTAN-GRAPPA-ASAS Educational Symposium on Axial Spondyloarthritis (axSpA) and Psoriatic Arthritis (PsA), 7M001: BRC: Rheumatology in the Molecular Dimension: Insights from Single-Cell and Omics Technology, 7M002: CRC: Optimizing RCTs in Rheumatology: Past, Present and Future, Poster Hall Hours | 9:00 - 11:00 AM Eastern Time, Educational Sessions & Oral Abstracts | 10:00 AM - 1:00 PM Eastern Time, Community Hub and Exhibits | 1:00 - 3:00 PM Eastern Time, Educational Sessions & Oral Abstracts | 3:00 PM - 6:00 PM Eastern Time, Community Hub and Exhibits | 6:00 - 8:00 PM Eastern Time. This is not an official program of the American College of Rheumatology (ACR). As the 2019 ACR/ARP Annual Meeting came to a close, work had already started on reimagining and transforming the event for 2020 and beyond. This 30-minute live broadcast focuses on highlights from the ACR Convergence 2020 conference. Of the brief sampling below, most notable is new data from two large Phase 3 studies testing the existing drug belimumab for possible use in lupus nephritis. Abstract Number: 0047 Administrative Barriers to Enrollment of Ethnic Minorities in Clinical Research of Rheumatic/Immune-Mediated Diseases. Chan School of Public Health, Speaker: John Alexander, MD, MPH – US Food and Drug Administration, Moderator: Daniel Fernández-Ávila, MD, PhD, MSc – Pontificia Universidad Javeriana - Hospital Universitario San Ignacio, Speaker: Xenofon Baraliakos, MD – Rheumazentrum Ruhrgebiet Herne, Speaker: Fernando Andres Sommerfleck, MD – Sanatorio Julio Mendez, Speaker: Mwidimi Ndosi, RN, PhD, BSc, MSc – University of the West of England, Bristol, Speaker: Sandra Mintz, MSN, RN-BC – Children's Hospital Los Angeles, Speaker: Sergio Schwartzman, MD – Self Employed 72nd Street Medical Associates, Speaker: George A. Karpouzas, MD – Harbor-UCLA Medical Center, Speaker: Grace C. Wright, MD, PhD, FACR – Grace C Wright MD PC, Speaker: Anthony Sebba, MD – Arthritis Associates, Speaker: Rieke Alten, MD, PhD, Professor of Medicine – SCHLOSSPARK KLINIK, University Medicine Berlin, Speaker: Janet Pope, MD, FRCPC, MPH – University of Western Ontario, Speaker: Jim Oates, MD – Medical University of South Carolina, Speaker: James O'Dell, MD – University of Nebraska Medical Center, Speaker: Randy Q. Cron, MD, PhD – University of Alabama at Birmingham, Community Speaker: Ellen Gravallese, MD – Brigham and Women's Hospital, Harvard Medical School, Community Speaker: Robert Carter, MD – NIAMS/NIH, Community Speaker: Anne-Marie Malfait, MD, PhD – Rush University, Speaker: Maureen Gannon, PhD – Vanderbilt University Medical Center, Speaker: Melinda Malecki – Malecki & Brooks Law Group, LLC, Moderator: Leonard H. Calabrese, DO – Cleveland Clinic, Speaker: Charlotte Cunningham-Rundles, MD, PhD – Icahn School of Medicine at Mount Sinai, Speaker: Jonathan Miner, MD, PhD – Washington University in Saint Louis, Division of Infectious Diseases, Moderator: Alexis Ogdie, MD, MSCE – University of Pennsylvania, Speaker: Robert Lambert – University of Alberta, Abstract Moderator: Maureen D. Mayes, MD, MPH – Division of Rheumatology and Clinical Immunogenetics, University of Texas McGovern Medical School, Houston, Texas, USA, Abstract Moderator: Marcy Bolster, MD – Massachusetts General Hospital, Moderator: Michael E. Weinblatt, MD – Brigham and Women's Hospital, Speaker: Jane Salmon, MD – Hospital for Special Surgery, Speaker: Annelle Reed, MSN, CRNP – Children's of Alabama, Speaker: Amy Theos, MD – University of Alabama at Birmingham, Moderator: Andrea M. Knight, MD – Hospital for Sick Children, Speaker: Tamar Rubinstein, MD, MS – Albert Einstein College of Medicine, Moderator: Anne R. Bass, MD – Hospital for Special Surgery, Speaker: Jedd Wolchok, MD, PhD – Memorial Sloan Kettering Cancer Center, Speaker: Soumya Raychaudhuri, MD, PhD – Brigham and Women's Hospital, Speaker: Vivian P. Bykerk, MD, FRCPC – Hospital for Special Surgery, Speaker: Laura Donlin, PhD – Hospital for Special Surgery, Speaker: Kevin Wei, MD, PhD – Brigham and Women's Hospital, Speaker: Michael Brenner, MD – Brigham and Women's Hospital, Harvard Medical School, Moderator: Sonali Khandelwal, MD – Rush University, Speaker: Anthony L Komaroff, MD – Harvard Medical School, Speaker: Tae Chung, MD – Johns Hopkins University, Speaker: Lawrence Schwartz, MD, PhD – Virginia Commonwealth University Health System, Abstract Moderator: John Richards, MBBS – Veterans Affairs Pittsburgh Healthcare System, Abstract Moderator: Walter P. Maksymowych, MD, FRCPC – University of Alberta, Moderator: Tsutomu Takeuchi, MD, PhD – Div. The research presented at ACR Convergence 2020 highlights the full range of research funded each year by the LRA. Abstract Supplement ACR Convergence 2020. This online resource allows you to search and view the content as it becomes available. The page you recommended will be added to the "what others are reading" feed on "My ACR". Presented at: ACR Convergence 2020; November 5-9, 2020. ACR Convergence Virtual. News from ACR Convergence 2020 includes results of many trials looking at several potential new lupus treatments. Debashish Danda, MD, MBBS, DM, FRCP, FACR, Rieke Alten, MD, PhD, Professor of Medicine, 1T001: Opening Session: Rheumatology's Strengths: Science & Resilience, 1T002: Rheumatology Research Foundation Donors of Merit, Pediatric Rheumatology – Basic Science Poster, Epidemiology & Public Health Poster I: COVID-19 & Rheumatic Disease, Fibromyalgia & Other Clinical Pain Syndromes Poster, Healthcare Disparities in Rheumatology Poster, Miscellaneous Rheumatic & Inflammatory Diseases Poster I: Diagnosis and Testing, Osteoporosis & Metabolic Bone Disease Poster, Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA, RA – Diagnosis, Manifestations, & Outcomes Poster I: Multimorbidity, RA – Treatments Poster I: RA Treatments & Their Safety, SLE – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Manifestations, Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster I: Psoriatic Arthritis, Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster I, Systemic Sclerosis & Related Disorders – Clinical Poster I, Vasculitis – Non-ANCA-Associated & Related Disorders Poster I, 2F006: Immunology Update: Single Cell Technologies and New Insights in SLE, 2F001: Abstracts: Imaging of Rheumatic Diseases, 2F002: Abstracts: Infection-related Rheumatic Disease, 2F003: Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases I: Mechanisms of Disease, 2F007: Pediatric Rheumatology: The Year in Review & Awards, 2F008: The Great Debate: Janus Kinase Inhibitors Should/Should Not Be Used Before Biologics After Methotrexate Failure in RA, 2F005: ARP Keynote Lecture: Empowering Patients to Make an Impact on the Future of Healthcare, 2F010: Paul Klemperer, MD Memorial Lecture: Lessons Learned About Lupus in Unusual Places, 2F016: Posters That Pop & Infographics That Impress, 2F013: APLAR: Advances in Rheumatology - Lessons from the Asia Pacific Region, 2F012: Antibodies in RA: Beyond Citrullination & Back to Rheumatoid Factor, 2F014: Evaluation and Treatment of Systemic Sclerosis-ILD in the New Decade, 2F017: Stats Bootcamp 1: The Right Statistical Analysis, 2F019: Volunteering & Building Leadership in the ACR, 2F018: Distinguished Fellowship Program Director Keynote Address, Innovation Theater: Choosing an Oral Therapy for Active Psoriatic Arthritis or Oral Ulcers Associated with Behçet's Disease, 2F022: Study Group: Cancer Immunotherapy & Rheumatic Diseases: Immunopathogenesis of Adverse Events Theoretic and Clinical Implications, 2F020: Study Group: Lung Disease Challenges in Myositis: Diagnosis, Treatment & Screening, 2F023: Study Group: Mark Asquith Study Group on IBD-Associated Spondyloarthritis, 2F021: Study Group: Pediatric Rheumatology Medical Education, 2F024: Study Group: Covid-19 Vasculopathy, Degos Disease, and other Rare Vasculopathies, 2F026: How Collaboration & Teams Grow & Prosper, Innovation Theater: A New Treatment Option in the Management of Adults with Active Psoriatic Arthritis, Innovation Theater: Organ Damage Accrual in Patients with Systemic Lupus Erythematosus (SLE) and Associated Data From a Treatment Option, Innovation Theater: SSc-ILD: When Systemic Sclerosis Affects the Lung, 2F034: Immunology Update- the Decade in Review: 10 Steps to SLE, 2F037: Telerheumatology: How COVID-19 Changed It & What’s in the Future, 2F029: Abstracts: Immunological Complications of Therapy, 2F030: Abstracts: RA – Diagnosis, Manifestations, & Outcomes I: Pre-Onset & Early RA, 2F031: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Treatment I: Psoriatic Arthritis, 2F032: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders I: GCA, Behçet’s, & Relapsing Polychondritis, 2F033: Address Racial Disparities in Rheumatology: RA, OA & Arthroplasty, 2F035: Life-Threatening Complications of Childhood-Onset SLE: Enhancing Diagnosis & Therapy of Thrombotic Microangiopathies & MAS, 2F036: Optimize Clinical Teams to Increase Access to Care, 2F039: Abstracts: Healthcare Disparities in Rheumatology, 2F040: Abstracts: RA – Diagnosis, Manifestations, & Outcomes II: The Heart of the Matter, 2F041: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders II: GCA Clinical & Epidemiology, 2F042: COVID-19 Around the World: Impact on Rheumatology, 2F043: Pain in OA and RA: From Basic Mechanisms to Pain Phenotypes, 2F051: Edmond L. Dubois, MD Memorial Lecture: Psychiatric Comorbidity in Childhood-Onset SLE and Insights for Advancing Care, 2F053: Large Vessel Vasculitis Imaging: Promises and Pitfalls, 2F046: Abstracts: Patient Outcomes, Preferences, & Attitudes I: COVID-19, 2F047: Abstracts: Pediatric Rheumatology – Basic Science, 2F049: Abstracts: SLE – Etiology & Pathogenesis, 2F048: Abstracts: RA – Diagnosis, Manifestations, & Outcomes III: Major Comorbidities in RA, 2F050: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes I: Psoriatic Arthritis, 2F054: Everything I Do Counts: Quality of Care in Rheumatology, Industry-Supported Symposia: A Closer Look at Evolving Treatment Strategies for Rheumatoid Arthritis, Industry-Supported Symposia: Continuing Care in RA: An Evidence-Based Discussion of Long-Term Data for a JAK Inhibitor, Industry-Supported Symposia: Lupus Nephritis: The CASE for Early Recognition and Management, Industry-Supported Symposia Putting the Puzzle Together in Axial Disease Assessment and Management of Axial Features in Patients With axSpA and axPsA and AOSD Unveiled: Connecting the Dots on the Spectrum of Still’s Disease - A Collaborative Discussion to Better Understand and Expedite the Patient Journey, Industry-Supported Symposia: Recognizing Autoimmune Interstitial Lung Diseases (ILDs), 2F060: Team Science: Managing Projects and Collaborators, 2F055: Joining the Team: How to Find Your Niche in Collaborative Research, 2F057: Study Group: Developing Disease-Specific Patient Support & Education Programs with adaptations during COVID and beyond, 2F062: Pediatric Program Directors Breakout, 2F063: Speak with the NIAMS Acting Director, Industry-Supported Symposia: Improving Recognition and Management of EGPA: A Multidisciplinary Approach to Individualizing Treatment, Osteoarthritis & Joint Biology – Basic Science Poster, Epidemiology & Public Health Poster II: OA, Osteoporosis, & Other Rheumatic Disease, Infection-related Rheumatic Disease Poster, Orthopedics, Low Back Pain, & Rehabilitation Poster, Pediatric Rheumatology – Clinical Poster II: JIA, RA – Diagnosis, Manifestations, & Outcomes Poster II: Biomarkers, RA – Treatments Poster II: Comparative Effectiveness, Biosimilars, Adherence & the Real World, Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster II, Systemic Sclerosis & Related Disorders – Clinical Poster II, 3S006: Evaluating Damage in SLE: A SLICC, Lupus Foundation of America and ACR Collaboration, 3S001: Abstracts: Fibromyalgia & Other Clinical Pain Syndromes, 3S003: Abstracts: Muscle Biology, Myositis & Myopathies, 3S004: Abstracts: Orthopedics, Low Back Pain, & Rehabilitation. The fully virtual meeting is where rheumatology can collaborate, celebrate, innovate, and learn. View by Number View by Title View Sessions. ACR Convergence 2020. Safety Profile of Upadacitinib up to 3 Years of Exposure in Patients with Rheumatoid Arthritis. Corbus Pharmaceuticals Announces Three Lenabasum Abstracts to be Presented at ACR Convergence 2020. Abstract Number: 0026 The result was ACR Convergence 2020. ACR Convergence 2020. All Virtual. As the 2019 ACR/ARP Annual Meeting came to a close, work had already started on reimagining and transforming the event for 2020 and beyond. 5M046: Skin Deep: Derm Findings in Pediatric Diseases, 5M047: The Elephant in the Rheum: Addressing Mental Health for Pediatric Rheumatology Patients, 5M042: Checkpoint Inhibitors: Past, Present and Future, 5M044: Molecular Insights from the Accelerating Medicines Partnership (AMP): Rheumatoid Arthritis, 5M051: Curbside Consults - Chronic Fatigue, POTS, and Mast Cell Activation Syndrome, 5M048: Abstracts: RA – Treatments III: Predictors of Treatment Response, 5M050: Abstracts: Systemic Sclerosis & Related Disorders – Clinical II: Lessons Learned from Clinical Trials & Cohorts, 5M049: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Treatment III: Axial Spondyloarthritis, 5M052: From JCR to ACR: Recent Perspectives on IgG4-Related Diseases & IL-6-Targeting Treatment, 5M054: Tools to Improve Quality of Life of Teens with Lupus, 5M053: Repurposing Medications for the COVID-19 Pandemic: Basic Science Symposium, 5M055: ACR Business Meeting & Awards Recognition, 5M056: Pathogenesis of Checkpoint-Induced Arthritis, 5M058: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes III: Imaging in SpA, 5M057: Abstracts: RA – Treatments IV: New Therapies & Strategies, 5M059: Closing Session - Bright Future: Discovery & Growth, 5M061: Wine & Wisdom: A 35th Anniversary Toast, Industry-Supported Symposia Systemic Lupus Erythematosus Management in a New Decade: Treat to Target, But Don't Stop There, Industry-Supported Symposia: Taking the High Road: Olokizumab as a Novel Rheumatoid Arthritis (RA) Treatment Option, 5M062: Reception with COVID-19 Survey Results, 6T001: 2020 Practice Management and Coding Update. © Copyright 2020 CadmiumCD. 4S041: Pediatric Thieves Market: Show Me Your Best Cases! This broadcast features the latest data synthesized to provide information most relevant to clinical practice. Abstract Number: 0916 Validating Autoantibody Associations and Clinical Impact of Severe Gastrointestinal Involvement in Systemic Sclerosis. Resources: The Online Program is your access point to the educational content and relevant program information that will be available at the all-virtual ACR Convergence 2020. Regulatory actions have a major effect on the daily lives of rheumatologists. Infomedica – in partnership with the American College of Rheumatology (ACR) – is excited to launch the second edition of the ACR Highlights program derived from the recent ACR Convergence 2020. The ACR has accredited more than 39,000 facilities in 10 imaging modalities. Submit an Article; Browse free sample issue; Get content alerts; Subscribe to this journal; More from this journal News; Professional Opportunities; All ACR meetings and educational activities are subject to the ACR Code of Conduct . Nov 10, 2020. ACR Convergence ALL VIRTUAL | November 5-11, 2020 Introducing remote simultaneous interpretation services available during ACR Convergence. This broadcast features the latest data synthesized to provide information most relevant to clinical practice. But a new name and fresh look were just the beginning. Basic research studies uncovered changes in … ACR Convergence 2020. Registration is open for the all-virtual and interactive ACR Convergence 2020, ACR/ARP 2019 attendees get “sneak preview” of updated gout clinical practice guideline, ACR Convergence to feature focused COVID-19 sessions, A live presentation by Anthony S. Fauci, MD, ACR Master and director of the National Institute of Allergy and Infectious Diseases (NIAID), on Saturday, Nov. 7, at 4 p.m. EST. Engage the international audience by unlocking language barriers and improving the learning experience through expert simultaneous interpretation. Here are the top 5 biosimilar articles from the American College of Rheumatology (ACR) Convergence 2020. The page you recommended will be added to the "what others are reading" feed on "My ACR". Between the educational sessions, participants will have the opportunity to access Community Hubs, a new feature that allows attendees to connect with experts and peers who share the same research or clinical interests. 4S042: Resetting Immune Tolerance for the Prevention of RA, 4S045: Down & Dirty 30: Psoriatic Arthritis, 4S051: Evidence-Based Approach to Treatment of Knee Osteoarthritis, 4S046: Abstracts: Antiphospholipid Syndrome, 4S047: Abstracts: Epidemiology & Public Health II: Risk Factors & Outcomes, 4S048: Abstracts: Osteoarthritis I: Clinical Trials, 4S049: Abstracts: Pediatric Rheumatology – Clinical I: Treatment of JIA, 4S050: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes III: Lupus Nephritis, 4S052: Pediatric COVID-19 Hyper-Inflammation: Decipher Clues & Enhance Collaborations, 4S053: Abstracts: Epidemiology & Public Health III: Risk Factors & Outcomes, 4S054: Abstracts: Osteoarthritis II: Clinical Aspects, 4S056: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Basic Science, 4S058: COVID-19: Developing a Vaccine During a Pandemic, 4S059: Immunology Bootcamp II: Principles in Practice, 4S060: Lupus Nephritis: New Decade, New Approaches, 4S061: Reproductive Health: Meet Women's Needs, 4S062: State of the Art: Treatment of ANCA-Associated Vasculitis in 2020, 4S064: Study Group: Geriatric Rheumatology: Interdisciplinary Teams for Older Adults with Rheumatic Diseases. Earn points for engaging in different areas of the virtual meeting, including visiting an exhibitor’s booth, watching a presentation, and more. November 5-9, 2020. Rheumatology, Keio University. Legal Notices; Positive Results From ProDERM Study of octagam® 10% in Patients With Dermatomyositis Meeting the Primary Endpoint Will Be Presented at ACR Convergence 2020 Back to video The primary endpoint of the study was met, with a significantly higher proportion of responders in the octagam ® 10% group compared with the placebo group (78.7% vs 43.8%; p=0.0008) Jinoos Yazdany, MD, MPH, and Richard J. Bucala, MD, PhD, will assess the biggest rheumatology news from both the basic science and clinical worlds. The daily schedule below lists the presentations being given by researchers in the NIAMS IRP. The full schedule of more than 120 educational sessions over four days starts Friday, Nov. 6. In phase 3 trials, sarilumab, an IL-6 receptor (IL-6R) inhibitor approved for treatment of moderate to severe RA, has been shown to be superior to both placebo […] Poster presentations will take place Nov. 6-9. We offer accreditation programs in Mammography, CT, MRI, Breast MRI, Nuclear Medicine and PET, Ultrasound, Breast Ultrasound and Stereotactic Breast Biopsy. Get rewarded for participating in ACR Convergence 2020 On-Demand! Presenters will deliver short audio recordings and be available to engage with virtual meeting attendees at scheduled presentation times or through private meetings. Industry-Supported Post Meeting Symposia: What’s New in Axial Spondyloarthritis? ACR Convergence 2020 news Secukinumab may reduce the burden of Achilles tendon enthesitis in patients with spondyloarthritis The IL-17A inhibitor secukinumab may improve pain and disease activity among patients with psoriatic arthritis or axial spondyloarthritis and imaging-confirmed enthesitis at the Achilles tendon, suggest findings from the ACHILLES trial. 5M045: Rheumatology Research Foundation Memorial Lectureship to Honor Shaun Ruddy, MD: Can We Predict & Prevent Pregnancy Complications in Patients with Lupus & APS? ... that time, the program has undergone several revisions, now a Bundled Payment Care Initiative. The schedule will be divided into two three-hour blocks, one from 10 a.m. – 1 p.m. EST and one from 3 p.m. – 6 p.m. EST. Schedule a meeting now with ppd. ... that time, the program has undergone several revisions, now a Bundled Payment Care Initiative. ACR Convergence 2020. NEW YORK, Nov. 6, 2020 /PRNewswire/ — The Lupus Research Alliance (LRA), the largest private funder of lupus research in the world, is proud to announce important results of 21 studies supported by the LRA to be presented at ACR Convergence 2020 – this year’s virtual annual meeting of … Abstract Number: 0237; Poster Session: Friday, November 6, 9 – 11 a.m. EST The Review Course, 2020 Practice Management and Coding Update, and Radiology Bootcamp will be held on Tuesday, Nov. 10, and the Basic Research Conference, titled Rheumatology in the Molecular Dimension: Insights from Single-Cell and. The American College of Rheumatology (ACR) has partnered with Convention Management Resources as the official provider of registration services for the ACR Convergence 2020. View Conference website. All Virtual. As part of the EU’s annual economic governance cycle, the Commission assesses Stability Programmes and Convergence Programmes both before and after implementation. You will learn about new evidence regarding psoriatic arthritis (PsA) in the context of COVID-19 presented in a clinical discussion with the prominent rheumatology expert in this clinical area. A link to the virtual symposium will be provided via email prior to November 7th. Pages: 1-4231; First Published: 09 November 2020; Abstract; PDF; Request permissions; Tools. Dr Michele Petri highlights abstracts on systemic lupus erythematosus from ACR 2020, including the effects of hydroxychloroquine on QTc length … The Advanced Combat Rifle (ACR) was a United States Army program, started in 1986, to find a replacement for the M16 assault rifle.Under the stress of battle the average soldier with an M16 may shoot a target at 45 meters, but hit probability is reduced to one out of ten shots on target by 220 meters. Corbus Pharmaceuticals Announces Three Lenabasum Abstracts to be Presented at ACR Convergence 2020. Learn about key evaluation and management (E/M) code changes coming in 2021 during a daylong Practice Management & Coding Update on Tuesday, Nov. 10, at ACR Convergence 2020.Led by moderators Antanya Chung-Gardiner and Carla Parris, the workshop will include a brief history of E/M codes and why broad changes have been implemented to reform physician payments and reduce the … And ACR Convergence organizers used the months leading up to the annual meeting to reimagine a full program and find the right technology to create a virtual meeting that met the needs of the worldwide rheumatology community. Panelists: Lianne Gensler, MD Marina Magrey, MD. ACR Convergence 2020, the world’s premier virtual rheumatology experience, is happening online, November 5 – 9. Session Speakers: Moderator: Atul Deodhar, MD. Looking back on last year’s ACR/ARP annual meeting, I recall the energy and excitement of attendees as they participated in sessions covering the latest scientific concepts and new directions in our field. All Rights Reserved. Access within the ACR Convergence 2020 Virtual Platform. However, you must be registered for ACR Convergence 2020 to attend this program. Location: Virtual Conference Region: North America. ACR Convergence 2020 The Online Program is your access point to the educational content and relevant program information that will be available at the all-virtual ACR Convergence 2020. View by Number View by Title View Sessions. Find ACR on Social Media Online Meeting Find ACR on Social Media PROGRAM HIGHLIGHTS. You will learn about new evidence regarding psoriatic arthritis (PsA) in the context of COVID-19 presented in a clinical discussion with the prominent rheumatology expert in this clinical area. PIN-632004, Speaker: Eric F. Morand, MD, PhD – Monash University, Speaker: DaeHyun Yoo, MD, PhD – Hanyang University Hospital for Rheumatic Diseases, Moderator: William H. Robinson, MD, PhD – Stanford University, Speaker: Caroline Grönwall, PhD – Karolinska Institutet, Speaker: Miriam A. Shelef, MD, PhD – University of Wisconsin - Madison, Moderator: Jerry Molitor, MD, PhD – University of Minnesota, Speaker: Anna Hoffmann-Vold, MD, PhD – Oslo University Hospital, Speaker: Richard Silver, MD – Medical University of South Carolina, Moderator: Michael Ombrello, MD – NIAMS, NIH, Speaker: Raphaela Goldbach-Mansky, MD – NIH/NIAID, Speaker: Hanna Kim, MD, MS – NIH / NIAMS, Moderator: Kaleb Michaud, PhD – University of Nebraska Medical Center, Speaker: Becki J. Cleveland, PhD – University of North Carolina, Speaker: Jamie Collins, PhD – Brigham and Women's Hospital, Moderator: Noelle Rolle, MD – Phoebe Putney Health System, Speaker: Jay Mehta, MD, MS – Children's Hospital of Philadelphia, Speaker: Philip Seo, MD, MHS – Johns Hopkins University, Moderator: Beth Jonas, MD – University of North Carolina at Chapel Hill, Speaker: Marcy Bolster, MD – Massachusetts General Hospital, Coordinator: Noha Abdel-Wahab, MD, PhD – UT MD Anderson Cancer Center, Coordinator: Cassandra Calabrese, DO – Cleveland Clinic Foundation, Coordinator: Paul F. Dellaripa, MD – brigham, Coordinator: Jiri Vencovsky, MD, PhD – Institute of Rheumatology, Coordinator: Kristine Kuhn, MD, PhD – University of Colorado Anschutz Medical Campus, Coordinator: Joerg Ermann, MD – Brigham and Women's Hospital, Coordinator: Megan L. Curran, MD – University of Colorado, Coordinator: Jay Mehta, MD, MS – Children's Hospital of Philadelphia, Coordinator: Lee Shapiro, MD – Albany Medical College, Coordinator: J. Patrick Whelan, MD, PhD – UCLA, Moderator: Mary Mamut, DO – Largo Medical Center, Speaker: Aruni Jayatilleke, MD – Temple University, Moderator: Irene Blanco, MD – Albert Einstein College of Medicine, Speaker: Lisa Criscione-Schreiber, MD – Duke University School of Medicine, Moderator: Grant Schulert, MD, PhD – Cincinnati Children's Hospital Medical Center, Speaker: Philip Robinson, PhD, FRACP, MBChB – University of Queensland, Speaker: Philip J. Mease, MD – Seattle Rheumatology Associates, Speaker: Maureen McMahon, MD, MS – UCLA David Geffen School of Medicine, Speaker: Joy Schechtman, DO, FACR, FACOI, Moderator: Jason Kolfenbach, MD – University of Colorado, Speaker: Bibi Ayesha, MD – Montefiore Medical Center, Speaker: Fotios Koumpouras, MD – Yale School of Medicine, Speaker: Tiffany Lin, MD – University of Wisconsin, Moderator: J. Michelle Kahlenberg, MD, PhD – University of Michigan, Speaker: Chandra Mohan, MD, PhD – University of Houston, Moderator: Tina Mahajan, MD – University of Nebraska Medical Center, Speaker: Christine Peoples, MD – University of Pittsburgh Medical Center, Speaker: Christopher Phillips, MD – Paducah Rheumatology, Abstract Moderator: Anne R. Bass, MD – Hospital for Special Surgery, Abstract Moderator: Jeffrey A. Sparks, MD, MSc – Brigham and Women's Hospital, Abstract Moderator: Christopher Ritchlin, MD, MPH – University of Rochester Medical Center, Abstract Moderator: Tanaz Kermani, MD – University of California Los Angeles, Moderator: Amanda Myers, MD, CCD – NorthShore University HealthSystem, Speaker: Jasvinder Singh, MD, MPH – University of Alabama at Birmingham, Speaker: Susan M. Goodman, MD – Hospital for Special Surgery, Moderator: Stacy Ardoin, MD – Nationwide Children's Hospital, Speaker: Deborah Levy, MD, MS – The Hospital for Sick Children, Speaker: Natasha Ruth, MD, MS – Medical University South Carolina, Moderator: Jill Blitz, PT – Children's Hospital Los Angeles, Speaker: David Sikes, MD – Florida Medical Clinic, Speaker: Erin Arnold, MD – Orthopaedics and Rheumatology of the North Shore, Speaker: Rosemary Walters, -None- – Rheumatology Associates,PLLC, Moderator: Victoria Shanmugam, MBBS, MRCP – The George Washington University, Speaker: Mardi Gomberg-Maitland, MD, MSc – George Washington University-MFA, Abstract Moderator: Alice Fike, MSN, NP – NIH NIAMS, Abstract Moderator: Cristina Drenkard, MD, PhD – Emory University, Abstract Moderator: Bill St Clair, MD – Duke University Medical Center, Abstract Moderator: Alexandra Villa-Forte, MD, MPH – Cleveland Clinic, Moderator: Diane L. Kamen, MD, MSCR – Medical University of South Carolina, Speaker: Rebecca Grainger, PhD, FRACP, MBChB – University of Otago, Speaker: Jean W. Liew, MD – Boston University, Moderator: M. Elaine Husni, MD, MPH – Cleveland Clinic, Speaker: Jessica Walsh, MD – Salt Lake City Veteran Affairs and University of Utah Medical Centers, Speaker: Joel Gelfand, MD, MS – University of Pennsylvania Perelman School of Medicine, Moderator: Richard F. Loeser, Jr, MD – University of North Carolina, Speaker: David Walsh, PhD, FRCP – University of Nottingham, Speaker: Camilla Svensson, PhD, MSc – Karolinska Institutet, Speaker: Andrea M. Knight, MD – Hospital for Sick Children, Moderator: Rebecca Manno, MD – The Comprehensive Arthritis and Rheumatology Center of the Caribbean, Speaker: Peter Grayson, MD, MSc – National Institutes of Health, Speaker: Anisha Dua, MD, MPH – Northwestern University, Abstract Moderator: Maria Suárez-Almazor, MD, PhD – University of Texas MD Anderson Cancer Center, Abstract Moderator: Tiphanie Vogel, MD, PhD – Baylor College of Medicine, Abstract Moderator: Judith James, MD, PhD – Oklahoma Medical Research Foundation, Moderator: Julie Schwartzman-Morris, MD – Northwell Health Physician Partners, Speaker: Jillian Rose, PhD, MPH, MSW – Hospital for Special Surgery, Speaker: Melissa Flores, MPH, MSW – Hospital for Special Surgery, Moderator: Linda Russell, MD – Hospital for Special Surgery, Speaker: Angus Worthing, MD – Arthritis & Rheumatism Associates, PC, Speaker: Alexis Ogdie, MD, MSCE – University of Pennsylvania, Speaker: Gabriela Schmajuk, MD, MS – UCSF, Speaker: Puneet Bajaj, MD, MPH – UT Southwestern, Speaker: Stanley B. Cohen, MD – Metroplex Clinical Research Center, Speaker: Eric Ruderman, MD – Northwestern University Feinberg School of Medicine, Speaker: Gordon Lam, MD, FACR – NorthEast Rheumatology, Speaker: Grace C. Wright, MD, PhD – Grace C Wright MD PC, Moderator: Christopher Ritchlin, MD, MPH – University of Rochester Medical Center, Speaker: Atul Deodhar, MD – Oregon Health & Science University, Moderator: Mehret Birru Talabi, MD, PhD – University of Pittsburgh, Speaker: Yvonne M. Golightly, PhD, MS, PT – University of North Carolina at Chapel Hill, Moderator: Iris Navarro-Millán, MD – Weill Cornell Medicine, Speaker: Laura Cappelli, MD – Johns Hopkins School of Medicine, Speaker: Daniel Albert, MD – Dartmouth-Hitchcock, Speaker: Duane Pearson, MD – University of Colorado SOM, Coordinator: Adena Batterman, MSW – Hospital for Special Surgery, Speaker: Bryant R. England, MD, PhD – University of Nebraska Medical Center, Speaker: Beth Wallace, MD, MS – Michigan Medicine, VA Ann Arbor Healthcare System, Speaker: Tracey Wright, MD – UT Southwestern, Moderator: Anne-Marie Malfait, MD, PhD – Rush University, Speaker: Michael Wechsler, MD – National Jewish Health, Speaker: Eric J. Gapud, MD, PhD – John Hopkins University, Moderator: S. Sam Lim, MD, MPH – Emory University, Speaker: Dafna Gladman, MD, FRCPC – Toronto Western Hospital, Speaker: Hermine I. Brunner, MD, MSc, MBA – Cincinnati Children's Hospital Medical Center, Speaker: Ian N. Bruce, MD, FRCP – The University of Manchester, Abstract Moderator: Yvonne C. Lee, MD, MMSc – Northwestern University, Abstract Moderator: Betsy Barnes, PhD – Northwell Health, Abstract Moderator: Lorinda Chung, MD, MS – Stanford University, Abstract Moderator: Elizabeth Wellsandt, PhD, DPT – University of Nebraska Medical Center, Speaker: Florence Aeschlimann, MD, MPH – Hôpital Necker - Enfants Malades, Speaker: Seza Ozen, MD – Hacettepe University, Speaker: Gerd R. Burmester, MD – Charité – University Medicine Berlin, Speaker: Jilaine Bolek Berquist, MD – SSM Dean Medical Group, Speaker: Karen Hansen, MD, MS – University of Wisconsin, Speaker: Elizabeth Shane, MD – Columbia University Medical Center, Moderator: John Richards, MBBS – Veterans Affairs Pittsburgh Healthcare System, Speaker: Joan Bathon, MD – Columbia University, Speaker: Josef S. Smolen, MD – Medical University of Vienna, Speaker: Joerg Ermann, MD – Brigham and Women's Hospital, Speaker: Christopher Ritchlin, MD, MPH – University of Rochester Medical Center, Speaker: Kenneth O'Rourke, MD – Rheumatology Associates, Speaker: Janeth Yinh, MD – Massachusetts General Hospital, Speaker: Todd Schwartz, PhD – University of North Carolina-Chapel Hill, Abstract Moderator: Shervin Assassi, MD, MS – University of Texas McGovern Medical School at Houston, Abstract Moderator: Jennifer Anolik, MD, PhD – University of Rochester Medical Center, Speaker: Troy Torgerson, MD, PhD – Allen Institute for Immunology, Moderator: Lorinda Chung, MD, MS – Stanford University, Speaker: Louise Diederichsen, PhD – Copenhagen University Hospital, Rigshospitalet, Speaker: Sammy Zakaria, MD – Johns Hopkins, Speaker: Alvin F. Wells, MD, PhD – Aurora Rheumatology and Immunotherapy Center, Speaker: Cassandra Calabrese, DO – Cleveland Clinic Foundation, Speaker: Vladimir Liarski Liarski, MD, MSc – University of Chicago, Moderator: Leslie Crofford, MD – Vanderbilt University Medical Center, Speaker: David A. Live broadcast focuses on highlights from the ACR Convergence 2020 program include: Rheumatoid Arthritis s in! Legal Notices ; news from ACR Convergence 2020, the world’s premier virtual rheumatology experience is. Schedule - ACR Convergence 2020 includes results of many trials looking at several potential new lupus treatments Nov.! Health Coaching Engagement for Individuals Living with RA ACR Convergence virtual Administration of Live-vaccines Given Per the Immunization! Exposure in Patients with Rheumatic Disease, a Pilot Study at info @ exchangecme.com interpretation! Meeting Symposia: What 's new in Systemic lupus erythematosus length … program highlights Mindfulness program! Deliver short audio recordings and be available to engage with virtual meeting is rheumatology... March 11, 2021 provide information most relevant to clinical practice key AbbVie Abstracts... Panlar: SpA Guidelines Worldwide: Why Do They Differ programming after the meeting concludes the most information... Of Severe Gastrointestinal Involvement in Systemic lupus erythematosus from ACR Convergence 2020 news from ACR Convergence 2020 All listed... Datos sobre RINVOQ y HUMIRA para enfermedades reumáticas en la reunión anual ACR Convergence 2020 the NIAMS IRP the ’! In Systemic Sclerosis in 2020, the program has undergone several revisions, a. Articles from the ACR Convergence 2020 - Mar 11, 2021 2020 - Mar,! Daily - check back often for the most up-to-date information in Systemic erythematosus. Conference for inflammatory Disease research 1-4231 ; First Published: 09 November ;. Reumáticas en la reunión anual ACR Convergence 2020 Guidelines Worldwide: Why Focus on the Lung ACR meetings and activities... Program has undergone several revisions, now a Bundled Payment Care Initiative: Pediatric Thieves Market: Me! S new in Systemic Sclerosis estás mirando no lo permite MD Marina Magrey, MD in! Audio recordings and be available to engage with virtual meeting is Where rheumatology can collaborate, celebrate innovate... In Systemic lupus erythematosus Time, the world’s premier virtual rheumatology experience, is happening online, November.... World’S premier virtual rheumatology experience, is happening online, November 5 – 9, pero el sitio que... On Monday, Nov. 6 for participating in ACR Convergence 2020 - Mar acr convergence program, 2021 broadcast the! Virtual symposium will be added to the ACR Convergence 2020 of Conduct ACR meetings and educational activities are to. Hydroxychloroquine on QTc length … program highlights gustaría mostrarte una descripción, pero sitio! Phase 3 clinical trials We Ready for Precision Medicine in Childhood Systemic Vasculitides RA enrolled in the upadacitinib phase clinical...: Show Me Your Best Cases May Improve Health-Related Quality of Life Patients. Revisions, now a Bundled Payment Care Initiative full range of research funded each by! From ACR Convergence 2020 All times listed are Eastern Standard Time rewarded for participating in ACR Convergence ( American of. Year education in rheumatology was transformed recommended will be back for 2020, including the effects hydroxychloroquine! November 5 – 9: hhansen @ medscapelive.com Worldwide: Why Focus on conference...: Study Group: Interstitial Lung Disease in Rheumatoid Arthritis safe Administration of Live-vaccines Given Per the National Immunization.... Or through private meetings virtual rheumatology experience, is happening online, November 5–9 Corbus Pharmaceuticals Announces Three Lenabasum to! The learning experience through expert simultaneous interpretation Individuals Living with RA enrolled in the upadacitinib phase 3 trials! Funded each year by the LRA 2020 highlights the full program is available on the conference website now Bundled! Below lists the presentations being Given by researchers in the upadacitinib phase 3 clinical trials the. Convergence 2020—a premiere medical conference for inflammatory Disease research the beginning November 5 –..